A Game-Changing Test in the Fight Against Esophageal Cancer
This is the game that TissueCypher is changing. Rather than have physicians make educated guesses about an individual patient ...
Pharmaceutical Technology1 天
CBP-1019 by Coherent Biopharma for Esophageal Cancer: Likelihood of Approval
CBP-1019 is under clinical development by Coherent Biopharma and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II drugs for Esophageal Cancer have a 25% phase transition ...
Can a cold actually turn out to be cancer? Signs you shouldn't ignore
Spotting chronic cough, unintended weight loss, recurrent infections, persistent fatigue, and difficulty swallowing early can ...
HealthDay on MSN8 天
Global Burden of Esophageal Cancer Remains Considerable
The burden of esophageal cancer (EC) remains substantial worldwide, with an upward trend seen in age-related EC bur ...
Jill Jacobson’s Health: About Her Cancer Battle Before Death
Jacobson died at the age of 70 in December 2024 after battling a ‘long illness,’ her friend and publicist confirmed.
Pharmaceutical Technology1 天
LM-302 by Bristol-Myers Squibb for Adenocarcinoma Of The Gastroesophageal Junction ...
LM-302 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction.
Pharmabiz23 小时
Mankind Pharma to market Innovent Biologics’ innovative PD-1 inhibitor, sintilimab to ...
Our Bureau, Mumbai Thursday, December 26, 2024, 16:40 Hrs [IST] ...